Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Pharmacological Research|December 14, 2022
BRD4 inhibitor suppresses melanoma metastasis via the SPINK6/EGFR-EphA2 pathwayRui Hu, Yao Li, Ying Guo, et al.Journal of Ethnopharmacology|April 6, 2024
Deciphering the pharmacological mechanisms of Shenlingbaizhu formula in antibiotic-associated diarrhea treatment: Network pharmacological analysis and experimental validationYan Chen, Xiangmei Meng, Haocheng Zheng, et al.Journal of Ethnopharmacology|July 22, 2023
Pharmacodynamics and pharmacological mechanism of Moluodan concentrated pill in the treatment of atrophic gastritis: A network pharmacological study and in vivo experimentsNi Lou, Mengyin Zhai, Zeqi Su, et al.Lung Cancer (Amsterdam, Netherlands)|October 27, 2019
Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment in locally advanced or metastatic non-small cell lung cancer with PD-L1 tumor proportion score 1% or greaterLongjiang She, Huabin Hu, Mengting Liao, et al.Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|March 2, 2022
Preoperative Ultrasound-Guided Incisional Biopsy Enhances the Pathological Accuracy of Incisional Biopsy of Cutaneous Melanoma: A Prospective Clinical Trial in Chinese PatientsNianzhou Yu, Lisha Wu, Juan Su, et al.Theranostics|January 3, 2024
Combined BET and MEK Inhibition synergistically suppresses melanoma by targeting YAP1Rui Hu, Huihui Hou, Yao Li, et al.Journal of Clinical Laboratory Analysis|October 17, 2020
Development and clinical application of a rapid SARS-CoV-2 antibody test strip: A multi-center assessment across ChinaMengting Liao, Jiawei Yan, Xinfeng Wang, et al.Scientific Reports|December 16, 2016
MiR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FOXO4Hui Li, Ruoyun Ouyang, Zi Wang, et al.Journal of Translational Medicine|March 20, 2025
CHI3L1: a key driver in gastritis-to-cancer transformationTao Li, Huizhong Jiang, Yucheng Gong, et al.Journal for Immunotherapy of Cancer|March 29, 2022
eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanomaXisha Chen, Kuansong Wang, Shilong Jiang, et al.Pageof 4